New drug combo shows promise against tough cancers
Disease control
Ongoing
This study tests a new experimental drug called ANV600, given alone or with another drug (pembrolizumab), in 240 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and see if the drug shrinks tumors. This is an ear…
Phase: PHASE1, PHASE2 • Sponsor: Anaveon AG • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC